In Libya, MSF teams have been providing comprehensive support to the public health system to improve care for TB patients, with a focus on drug-resistant tuberculosis. In 2019, MSF worked alongside with the Ministry of Health to open the first ward in the country for the treatment of multidrug-resistant TB (MDR-TB) in Misrata. MSF also supported TB case management and treatment by providing GeneXpert machines and cartridges to the National Center for Disease Control (NCDC) in Misrata and to Abu Sitta hospital in Tripoli. MSF teams also manage outpatient TB departments in Misrata and Zuwara.

In 2020 MSF supported Libya’s National Tuberculosis Progamme (NTP) and Abu Sitta hospital in treating TB patients from both Libyan and migrant communities. Two MSF doctors and specialist TB nurses work in the NTP centre and in Abu Sitta hospital to provide daily support to TB patients. Iin 2021, MSF teams conducted 7,128 outpatient consultations in the NTP centre and started on treatment 208 patients who were referred from detention centres and prisons across Libya. MSF also focused on rallying the necessary support and redirecting global funds through the establishment of the TB Actors’ Group, where MSF facilitates a monthly meeting with stakeholders all around the country for identifying and anticipating gaps and working to cover them.